Safety of Cyproheptadine, an Orexigenic Drug. Analysis of the French National Pharmacovigilance Data-Base and Systematic Review

• Main Authors: Valérie Bertrand (Author), Nathalie Massy (Author), Nancy Vegas (Author), Valérie Gras (Author), Christel Chalouhi (Author), Marie-Pierre Tavolacci (Author), Véronique Abadie (Author)
• Format: Book
• Published: Frontiers Media S.A., 2021-09-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Objectives: Cyproheptadine is a first-generation H1-antihistamine drug first that was distributed in the 1960s. While its orexigenic effect was observed early, cyproheptadine is not yet authorized for this indication in all countries today. There is an increasing medical interest and demand for the...